Shelley McCloskey

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada.

Stemcell Technologies, Inc. wholesales medical and hospital equipment. Its products include cell culture media and supplements, cell isolation products, primary and cultured cells, cell storage media, matrices and substrates, and cytokines. The firm offers contact assay services, custom solutions, product and scientific support, standardization tools, training programs, and science communication services. The company was founded by Allen Eaves in 1993 and is headquartered in Tukwila, WA.

Xantrex Technology, Inc. manufactures power supplies. It specializes in charger and inverter, power inverter, battery charger and backup power. The company is headquartered in Burnaby, Canada.

Inex Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer.